Posttraumatic Stress Disorder Symptomatology and Substance Use in an Outpatient Concurrent Disorders Sample.
alcohol
cannabis
concurrent disorders
posttraumatic stress disorder
substance use
Journal
Canadian journal of psychiatry. Revue canadienne de psychiatrie
ISSN: 1497-0015
Titre abrégé: Can J Psychiatry
Pays: United States
ID NLM: 7904187
Informations de publication
Date de publication:
09 2021
09 2021
Historique:
pubmed:
22
4
2021
medline:
26
10
2021
entrez:
21
4
2021
Statut:
ppublish
Résumé
Posttraumatic stress disorder (PTSD) and substance use disorders (SUDs) present a complex and often severe clinical presentation within a concurrent disorders context. The objective of this study was to examine associations between PTSD symptoms and SUD outcomes to better understand the clinical phenomenon of comorbid PTSD and SUD. Multivariate statistical methods were used to test the hypothesis that elevated PTSD symptoms, both at the level of global severity and specific PTSD symptom clusters, are associated with greater substance use and related problems. Data were collected from an intake assessment battery within a specialized concurrent disorders outpatient service in Hamilton, ON. The sample comprised 326 participants (mean age = 37.19, 45.4% female). Structural equation models examined associations between PTSD and alcohol, cannabis, and substance use frequency and problems, controlling for age and sex. Alcohol was ultimately dropped from the model due to non-significant bivariate associations. Higher global PTSD symptomatology was significantly associated with higher cannabis and other substance use frequency and related problems. Analyses using PTSD cluster scores showed higher scores for alterations in arousal were positively associated with cannabis-related problems, drug-related problems, and cannabis and other substance use frequency. Avoidance was significantly associated with cannabis frequency and cannabis-related problems. In general, effect sizes were small in magnitude, accounting for between 9% and 25% of variance. Significant cluster-level associations indicate the importance of specific PTSD symptoms (hyperarousal, avoidance) in relation to substance use when identifying therapeutic targets among individuals presenting with comorbid PTSD-SUD. This multivariate approach provides a higher resolution and potentially more clinically informative representation of the complex clinical presentation of PTSD and SUD in a concurrent disorder population and could guide the development of more effective treatment paths.
Identifiants
pubmed: 33878938
doi: 10.1177/07067437211011851
pmc: PMC8504290
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
788-797Références
Addiction. 2002 Dec;97 Suppl 1:98-108
pubmed: 12460132
Addict Behav. 1995 Sep-Oct;20(5):643-55
pubmed: 8712061
J Trauma Stress. 2008 Apr;21(2):173-80
pubmed: 18404637
Schizophr Res. 2011 Jun;129(1):42-6
pubmed: 21511440
J Clin Med. 2020 Jul 28;9(8):
pubmed: 32731398
Arch Gen Psychiatry. 2003 Feb;60(2):184-9
pubmed: 12578436
Schizophr Bull. 2009 Mar;35(2):383-402
pubmed: 19011234
Addict Behav. 2004 Nov;29(8):1665-72
pubmed: 15451135
J Psychiatr Res. 2016 Nov;82:16-22
pubmed: 27455424
Eur Addict Res. 2005;11(1):22-31
pubmed: 15608468
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Drug Alcohol Depend. 2010 Jul 1;110(1-2):137-43
pubmed: 20347232
Addiction. 1993 Jun;88(6):791-804
pubmed: 8329970
J Anxiety Disord. 2011 Apr;25(3):456-65
pubmed: 21168991
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Psychother Psychosom. 2017;86(3):150-161
pubmed: 28490022
Am J Addict. 2018 Jan;27(1):23-28
pubmed: 29251380
Am J Psychiatry. 1998 Jan;155(1):127-8
pubmed: 9433351
Addict Behav. 2010 Jan;35(1):64-7
pubmed: 19729250
J Addict Med. 2017 Mar/Apr;11(2):119-125
pubmed: 28079572
J Trauma Stress. 2015 Dec;28(6):489-98
pubmed: 26606250
Addiction. 2008 Jun;103(6):1039-47
pubmed: 18373724
Addict Behav. 2012 Jan;37(1):36-41
pubmed: 21937169
J Dual Diagn. 2019 Jan-Mar;15(1):56-66
pubmed: 30806190
Int J Methods Psychiatr Res. 2008 Jun;17 Suppl 1:S50-9
pubmed: 18543363
Am J Psychiatry. 2010 Jan;167(1):95-101
pubmed: 19917596
Clin Psychol Rev. 2015 Jun;38:25-38
pubmed: 25792193
Addict Behav. 2018 Jan;76:188-194
pubmed: 28846939
Addict Behav. 2019 Mar;90:369-377
pubmed: 30529244
Curr Psychiatry Rep. 2016 Aug;18(8):70
pubmed: 27278509
Psychol Med. 2019 Jul;49(9):1574-1580
pubmed: 30176957
Can J Psychiatry. 2008 Dec;53(12):800-9
pubmed: 19087478
J Abnorm Psychol. 2014 Feb;123(1):237-47
pubmed: 24661174
Cannabis. 2019;2(1):39-52
pubmed: 33870105
Psychol Addict Behav. 2018 May;32(3):277-288
pubmed: 29595297
Psychol Psychother. 2017 Jun;90(2):235-243
pubmed: 27561944
Addict Behav. 2015 Nov;50:205-12
pubmed: 26160523
CNS Neurosci Ther. 2008 Fall;14(3):171-81
pubmed: 18801110
J Anxiety Disord. 2010 Jan;24(1):55-62
pubmed: 19767174
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941